The U.S. Food and Drug Administration (FDA) has just released a new update in regards to the treatment options for COVID-19. As a result of the update, the FDA has removed the authorization for two monoclonal antibody treatments. Starting January 24, 2022, these treatments will only be authorized in certain regions. In the statement posted on FDA’s website, more information …
The FDA rules just changed on COVID-10 monoclonal antibody treatments
Slash Gear - 25 Jan 2022 22:09
The U.S. Food and Drug Administration (FDA) has just released a new update in regards to the treatment options for COVID-19. As a result of the update, the FDA has removed the authorization for two monoclonal antibody treatments. Starting January 24, 2022, these treatments will only be authorized in certain regions. In the statement posted on FDA’s website, more information …
Share this Article
Recommended